Duration of Migraine Is a Predictor for Response to Botulinum Toxin Type A.
Eross, Eric J.; Gladstone, Jonathan P.; Lewis, Susan; Rogers, Robert; Dodick, David W.; Headache: The Journal of Head & Face Pain, 2005, vol. 45, issue 4, p 308, ISSN 00178748. ISBN 00178748.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef